Home › Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101
 

Keywords :   


Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101

2014-07-21 15:41:01| Logistics - Topix.net

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

Tags: iii global trial phase

Category:Transportation and Logistics

Latest from this category

All news
16.11Atlantic Tropical Weather Outlook
16.11Eastern North Pacific Tropical Weather Outlook
16.11Tropical Storm Sara Graphics
16.11Summary for Tropical Storm Sara (AT4/AL192024)
16.11Tropical Storm Sara Public Advisory Number 10A
16.11Tropical Storm Sara Graphics
16.11Tropical Storm Sara Wind Speed Probabilities Number 10
16.11Summary for Tropical Storm Sara (AT4/AL192024)
Transportation and Logistics »
16.11 & A
16.11
16.11Adley Rutschman__
16.11 L NB42380
16.11
16.11S.H.Figuarts
16.11RUSSELUNO
16.11 5
More »